Moreover, the present results showed that TTX induced an increase in the liver damage indicators, AST and ALT [27], as well as in the markers of kidney damage, BUN and CRE [28], in the blood in all doses of TTX-treated mice (Figure 4). The gene discussed is GPT; the disease is Nephropathy.